NIH Awards Startup Cellular Research $360K to Develop Array-based Noninvasive Prenatal T21 Test | GenomeWeb

Cellular Research, a Bay Area company established a year ago by the cofounders of Affymetrix and Fluidigm, has received federal funding to develop a non-invasive test for detecting Down syndrome in prenatal samples using a new array-based DNA molecule counting approach.

According to the abstract of the $360,000 National Institutes of Health grant, Cellular Research aims to develop a "faster and cheaper single-molecule counting system" that will rival a non-invasive massively parallel sequencing test to detect trisomy 21 in fetal DNA present in maternal plasma.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."